Institute for Cancer Research
Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded.
The Institute has internationally strong research groups within biochemistry, cell and tumor biology, genetics, radiation biology, immunology and cancer prevention. For more than 30 years there has been a close interaction between researchers at the Institute and cancer surgeons, oncologists and pathologists. This emphasis on translational science has resulted in numerous clinical protocols based on in-house research, and the Institute is a key partner in the Comprehensive Cancer Center, organizationally under the Division of Surgery and Cancer Treatment at Oslo University Hospital.
Scientific production - Institute for Cancer Research
Annual report 2015 (pdf format)
The board of the Norwegian Cancer Society will October 24th decide which research projects that will be funded. All applications have been peer reviewed internationally. Those receiving funding will be contacted prior to the event.
The announcement event take place on Friday October 28th at 10-10 AM in the "Professorboligen" at the University of Oslo. There will be talks held by a scientist, a fund-raiser, and a personal story will be told. There will also be an artistic peformance, and refreshments will be served.
Final date for registration: October 25th
Mouldy Sioud (photo) from the Department of Immunology at the Instiute for Cancer Research is senior author on an article recently published in Oncotarget (journal impact factor 6.36), entitled "Cancer cell-binding peptide fused Fc domain activates immune effector cells and blocks tumor growth".
Lina Prasmickaite from the Department of Tumor Biology at the Institute for Cancer Research has spent several years studying why certain cancer cells become immune against treatment. Her research on this subject is presented in a popular science article (in Norwegian) recently published by the Norwegian Cancer Society.
Welcome to the next Oslo University Hospital (OUH) research seminar entitled "Medical imaging in cardiac research".
Time: Monday, October 10th, 2016, at 14:30 – 16:00.
Place: Green Auditorium, Rikshospitalet, Sognsvannsveien 20, Oslo.
Speakers: Ivar Sjaastad, Emil Espe, Einar Hopp, Thor Edvardsen and Espen Remme.
The Norwegian Cancer Society have recently published a popular science article (in Norwegian) presenting the work of Gunhild Mælandsmo and Kjersti Flatmark, both from the Department of Tumor Biology at the Institute for Cancer Research. The scientists explains how their research on colorectal cancer may improve the methods of personalized medicine, and how the MetAction study, which is supported by the Norwegian Cancer Society, may contribute to the development of more precise cancer treatments in the future.
John Arne Dahl (photo), from Department of Microbiology has published a collaborative study entitled "Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition", in the 22nd September issue of Nature (journal impact factor 41.5).
The study was carried out together with the lab of Arne Klungland, Department of Microbiology, and Bing Ren, University of California and Ludwig Institute for Cancer Research, San Diego.
The findings are also covered in a news article on the web site of the Ludwig Institute for Cancer Research.
Announcement of research funding from the Norwegian Cancer Society
Oct 20, 2016
Oct 18, 2016
50 years anniversary Institute for Surgical Research
Oct 11, 2016
Inst. for Cancer Research
Data including GROMACS input files for atomistic molecular dynamics simulations of mixed, asymmetric bilayers including molecular topologies, equilibrated structures, and force field for lipids compatible with OPLS-AA parameters
Data Brief, 7, 1171-1174
Journal Impact Factor > 5, first or last author from the Institute for Cancer Research